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Sepsis syndrome stimulates proximal tubule cholesterol synthe- Previous work from this laboratory has demonstrated
sis and suppresses the SR-B1 cholesterol transporter. that renal cortical/proximal tubular cell cholesterol accu-
Background. Previous studies demonstrate that renal corti- mulation is an integral component of the kidney’s re-cal/proximal tubule cholesterol accumulation is part of the re-
sponse to tissue “stress” [1–9]. For example, within 24 tonal “stress response.” The present study was performed to help
48 hours following heterogeneous forms of renal injurydefine underlying mechanisms, using experimental sepsis as a
test model. (for example, renal ischemia, rhabdomyolysis, nephrotoxic
Methods. Male CD-1 mice and female low-density lipopro- serum nephritis, urinary tract obstruction, heat shock,
tein receptor (LDLR) knockout mice were injected with a dehydration, sepsis syndrome), 20 to 30% increments inheat-killed Escherichia coli suspension. Renal cortex and serum
free cholesterol (FC) levels result [1, 2, 4, 5]. A correlatewere obtained from these and control mice either 4, 6, or 18
hours later. Tissues samples were assayed for free cholesterol of this process is a shuttling of FC into cholesteryl ester
(FC), cholesteryl esters (CE), HMG CoA reductase (HMGCR) (CE) “storage” pools, causing the latter to rise as much
mRNA, and SR-B1 [the high-density lipoprotein (HDL) recep- as 10- to 20-fold over control tissue values [2, 4, 5]. While
tor/cholesterol transporter]. Statin effects on renal cortical
all of the metabolic consequences of these FC/CE incre-HMGCR mRNA and FC/CE levels also were assessed. Finally,
ments remain to be defined, one documented result isthe impact of serum from septic versus normal mice on cultured
proximal tubule (HK-2) cell cholesterol levels was assessed. increased proximal tubular cell resistance to superimposed
Results. Sepsis induced approximately 30% and 300 to ischemic or nephrotoxic attack, so-called acquired cyto-
500% increases in renal FC and CE content, respectively. Cho- resistance [10–18]. The mechanistic link between cytoresis-lesterol accumulation was not blunted in LDLR/ mice ver-
tance and cholesterol elevations has been established bysus their controls. Statin therapy also did not alter sepsis-
experiments demonstrating that cholesterol reductions,induced renal FC/CE accumulation. However, statin treatment
exerted no discernible intra-renal activity (for example, no induced by heterogeneous means, can both reverse ac-
rise in renal HMGCR mRNA), despite significant extra-renal quired cytoresistance, and predispose otherwise normal
activity (25% reduction in serum cholesterol; 400% increase
cells to superimposed ischemic or toxic attack [1, 7, 8].in hepatic HMGCR mRNA). HK-2 cells exposed to septic
While cholesterol accumulation appears to be a ubiq-serum sustained a 40% cholesterol increase, compared to cells
exposed to control serum. This response was completely statin uitous response to acute renal injury, the mechanisms by
inhibited, proving that de novo synthesis was involved. Sepsis which it occurs may vary, depending on the nature of the
markedly suppressed renal levels of SR-B1 (an FC efflux pro- initiating insult. For example, in the case of heat shocktein). Renal HMGCR mRNA did not fall despite sepsis trig-
and myoglobinuric renal injury, an increase in 3-hydroxy-gered cholesterol loading, indicating a failure of negative feed-
3-methylglutaryl coenzyme A (HMG CoA) reductaseback activity.
Conclusions. Sepsis-induced renal cholesterol accumulation (HMGCR) occurs, implying that increased renal choles-
is not simply an intrinsic renal response, since it can be en- terol synthesis is involved [5]. That statin treatment pre-
hanced by circulating “stress factors” that drive HMGCR activ-
vents cholesterol accumulation in cultured HK-2 cellsity. Sepsis also down-regulates SR-B1. Thus, decreased cell FC
following Fe-mediated injury further supports this linkefflux, coupled with increased synthesis, may synergistically
induce the post-sepsis cholesterol overload state. [2]. In contrast, with sepsis syndrome no increase in renal
cortical HMGCR protein results and it remains at control
tissue levels [5]. This suggests that factors other than deKey words: endotoxin, cholesteryl esters, free cholesterol, HMG CoA
reductase, statins, LDL receptor. novo cholesterol synthesis, for example, increased uptake
of circulating cholesterol [such as, via the low-densityReceived for publication June 11, 2002
lipoprotein (LDL) receptor], or decreased cellular cho-and in revised form August 6, 2002
Accepted for publication August 29, 2002 lesterol efflux (such as, via the scavenger receptor B1;
SR-B1) may be involved [19–24]. 2003 by the International Society of Nephrology
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Given that sepsis syndrome is such a frequent renal ready for IP injection. Following the E. coli injections,
the mice were returned to their former diets. Approxi-insult, the present study was undertaken to elucidate
mechanisms by which renal cortical cholesterol accumu- mately 18 hours later, they were deeply anesthetized
with pentobarbital (1 to 2 mg IP), the abdominal cavitieslation results. To this end, we employed a previously de-
scribed sepsis model (intraperitoneal injection of heat- were opened, and the mice were exanguinated from the
inferior vena cava. One kidney per animal was removed,killed Escherichia coli) for study because it induces renal
cortical cholesterol overload without inducing overt his- iced, and the cortex was subjected to chloroform:metha-
nol extraction for subsequent analysis of cholesterol con-tologic damage [5]. Hence, the results obtained should
reflect tissue “stress” without the potentially confound- tent [free cholesterol (FC) and cholesteryl esters (CE)]
by gas chromatography (GC), as previously describeding variables arising from tubular necrosis, cast forma-
tion, or other forms of renal histologic damage. [2]. The blood samples were saved and analyzed for
blood urea nitrogen (BUN) and creatinine concentra-
tions by autoanalyzer technology. As an additional surro-
METHODS
gate marker of the severity of sepsis syndrome, plasma
Effect of sepsis on renal cortical cholesterol levels lactate dehydrogenase (LDH) levels, released from mul-
with and without statin therapy tiple tissues in response to injury, were assessed. To
establish control values for the above assessments (thatAs noted above, it has been previously established that
experimental sepsis induces renal cortical cholesterol is, in the absence of sepsis), kidney and serum samples
were obtained from six normal mice and subjected toaccumulation without an apparent increase in HMGCR
protein [5]. However, it remains possible that increased the above renal cholesterol and plasma analyses.
activity of constitutively expressed HMGCR might still
HMGCR mRNA levels in the setting of sepsisdrive excess cholesterol synthesis. The following experi-
ment was designed to test this possibility, using an Twelve mice were injected with 2 mL of the heat-
killed E. coli suspension. Either 4 or 18 hours later (NHMGCR inhibitor as a pharmacologic probe. The hy-
pothesis was as follows: if sepsis-induced cholesterol 6 each), the mice were anesthetized with pentobarbital,
the abdominal cavities were opened, a heparinized bloodaccumulation is HMGCR dependent, then statin admin-
istration theoretically should diminish this response. To- sample was obtained from the inferior vena cava (from
the 18 hour mice), and then both kidneys were resected.ward this end, 20 CD-1 male mice (25 to 35 g; Charles
River, Wilmington, MA, USA) were divided into two The 18-hour plasma samples were saved for BUN and
cholesterol analysis. The cortex of one kidney was usedequal groups and received either (1) oral atorvastatin
(“statin”) containing diet [5]; or (2) a control diet. The for RNA extraction and subsequent HMGCR mRNA
and GADPH mRNA analysis by reverse transcriptaseatorvastatin diet consisted of normal mouse chow to
which 1.5 mg atorvastatin (Pfizer/Warner Lambert; Ann polymerase chain reaction (RT-PCR), as previously per-
formed in this laboratory [9]. The other kidney was usedArbor, MI, USA) was added to each gram of chow. This
was done by pulverizing the chow pellets, moisturizing to assess cholesterol levels. Twelve mice, injected with
the E. coli carrier (saline), were treated in an identicalit with water, adding atorvastatin, and then shaping it
back into pellets and allowing them to dry. The control fashion and used to collect control plasma and kidney
samples at both the 4- and 18-hour time points. Thediet was treated in an identical fashion but without statin
addition. This diet previously has been demonstrated mRNA results were expressed as HMGCR mRNA/
GADPH mRNA ratios following densitometric analysisnot to affect weight gain, but it does induce an approxi-
mate 25% reduction in total serum cholesterol levels of band density/width [9].
within three days [5]. After three days on these respective
Impact of statin therapy on HMGCR mRNAdiets, the mice received intraperitoneal (IP) injections
expression in normal miceof 2 mL of a heat-killed E coli suspension (1  1010
organisms/mL normal saline), prepared as previously de- The following experiment was undertaken to ascertain
whether statin therapy increases renal HMGCR mRNAscribed [5]. In brief, colonies of E. coli, isolated from
the urine of two patients with urosepsis, were expanded expression in normal mice, as would be expected if the
drug effectively inhibits renal HMGCR enzyme activityby culture in “Terrific” medium (Sigma, St. Louis, MO,
USA). After three days in culture, at which time an (that is, a compensatory increase in HMGCR mRNA
should result). Six mice were fed either the atorvastatinobvious slurry was produced, the bacteria were pelleted
by centrifugation, washed with saline, re-suspended in or the control diet (N 3 each) for three days. The mice
were then anesthetized with pentobarbital, a plasmasaline, and stored at –20C. Prior to use, 2 mL aliquots
were thawed and placed into a boiling water bath for 20 sample was obtained for cholesterol analysis, and then
the kidneys, and a piece of liver, were removed. Bothminutes, rendering the organisms non-viable but leaving
endotoxin intact [25]. After cooling, the bacteria were hepatic and renal tissues (1 kidney per animal) were
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extracted for RNA and subsequently analyzed for to ascertain whether direct exposure to E. coli/endotoxin
HMGCR mRNA, as noted above. The second kidney directly alters tubular cell cholesterol accumulation. To
was used for FC and CE analysis. this end, six T25 flasks of HK-2 cells were divided into
two groups of three: (1) exposure to the E. coli prepara-
Cultured HK-2 proximal tubular cell tion (0.33 mL per 5 mL of culture media that contained
cholesterol homeostasis 13.5% heat-inactivated normal mouse serum (N  3;
Impact of sepsis serum. The following experiment was Gibco, Grand Island, NY, USA); or (2) addition of 0.33
conducted to assess whether a septic milieu, mimicked mL of normal saline, instead of the E. coli (N  3).
in vitro, can induce alterations in proximal tubular cell After the 18 hour incubations, total cell cholesterol was
cholesterol homeostasis. To this end, six mice were in- determined, as noted earlier in this article.
jected with the E. coli preparation. Six additional mice
SR-B1 expression following the induction of sepsisreceived the E. coli vehicle (2 mL sterile saline). Approx-
imately four hours later, the mice were anesthetized with Scavenger receptor B1 (SR-B1) can significantly im-
pentobarbital and 0.5 mL blood samples per mouse pact cellular FC and CE levels in cells, both by increasing
were obtained from the inferior vena cava. The sera were the CE influx and by driving the FC efflux by facilitation
separated and subjected to complement inactivation of its aqueous diffusion through the plasma membrane
(heating at 56C 30 min). Pools of serum from both to circulating HDL [21–23]. Hence, the goal of this exper-
septic and control mice were prepared, and then aliquots iment was to determine whether acute sepsis syndrome,
were added to subconfluent proximal tubule (HK-2) cells with its attendant renal cholesterol increments, alters
grown in T25 flasks 3 days (N  6 per group). Prior SR-B1 expression. To this end, 16 mice were subjected
to the serum addition, the cells were maintained in kera- to the sepsis protocol, and after either four (N  4), six
tinocyte serum-free medium (K-SFM) as previously de- (N 4), or 18 (N 6) hours the mice were anesthetized
scribed [26]. The serum samples were added to achieve with pentobarbital and the kidneys were removed. Si-
a final concentration of approximately 13.5%. The cells multaneously obtained kidneys from mice subjected to
were incubated for 18 hours and then the media samples saline carrier, rather than E. coli, injection were har-
were removed and saved. The flasks were placed on ice, vested also (N 4 at each of the three time points). The
rinsed twice with Hanks balanced salt solution (HBSS), kidneys were iced, the cortices dissected, and prepared
and then the cells were collected with a scraper. The for Western blot analysis, as previously described [5].
cells were pelleted by centrifugation, and the lipids were Seven micrograms of protein extract were electropho-
extracted in chloroform:methanol [5]. Total cholesterol
resed through a 12% Bis-Tris acrylamide gel (Invitrogen,
content was measured with a commercially available en-
Carlsbad, CA, USA) and then probed with rabbit poly-zymatic assay kit (Sigma), as previously used and vali-
clonal anti-SR-B1 antibody (catalog number NB-400-dated in this laboratory [1]. (Note: this enzymatic assay,
104; Novus Biologicals, Littleton, CO, USA). Donkeyrather than GC analysis, was used because of the rela-
anti-rabbit IgG (peroxidase-linked, species specific wholetively small sample sizes obtained from T25 flasks. T25
antibody; Amersham Pharmacia Biotech, Uppsala, Swe-flasks, rather than larger flasks, were used because of the
den) was used as the secondary antibody. Detection wassmall quantities of serum that could be obtained from
by enhanced chemiluminescence (ECL), as previouslyeach mouse). Total cholesterol values were expressed
described [5]. To confirm the specificity of the Westernas nmoles cholesterol/mol phospholipid phosphate [1].
analysis, gels were run in the same fashion, except forAdditionally, the cholesterol content in the media was
the omission of the primary anti-SR-B1 antibody. Equaldetermined to calculate the starting whole serum choles-
protein loading/transfer was confirmed by India ink stain-terol level.
ing of the gels. Statistical comparisons of SR-B1 expres-Impact of statin therapy on sepsis serum-mediated cellu-
sion was assessed by subjecting the SR-B1 band to densi-lar cholesterol increases. The following experiment was
tometric analysis, followed by separate unpaired Studentperformed to assess whether HMGCR inhibition would
t tests for the four, six, and 18 hour results.block increases in cellular cholesterol that were evoked
To determine whether changes in SR-B1 in the aboveby the addition of sepsis serum (Results section). To this
experiments are unique to sepsis, its expression in a sec-end, the experiment described earlier in this study was
ond model of cell injury-induced cholesterol overloadrepeated exactly, with the exception that 10mol/L mev-
was studied: the glycerol-induced ARF model [4, 18].astatin was added to each of the flasks at the same time
To this end, six mice were injected with 10 mL/kg ofas the serum addition. Of note, it was determined pre-
50% glycerol (equally divided IM doses into each upperviously that this mevastatin concentration effectively in-
hind limb). Eighteen hours later they were anesthetized;hibits HK-2 cell HMGCR [5].
the kidneys were removed, and renal cortical protein ex-Direct impact of bacteria exposure on HK-2 cell choles-
terol levels. The following experiment was undertaken tracts probed for SR-B1, as noted earlier. The results
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Fig. 1. Renal cortical free cholesterol (FC)
and cholesteryl ester (CE) levels in control
mice and in mice 18 hours following E. coli
injection (sepsis), or sepsis (S) concomitant
statin treatment (S  statin). Sepsis caused a
dramatic increase in both FC and CE levels,
and this result was not significantly blunted
by concomitant statin treatment.
were compared to those that had been obtained simulta- re-warming period (from 4C to 37C), each tubule prep-
aration was suspended in an experimentation buffer [16]neously using cortical tissues from five normal mice.
to a concentration of approximately 2 mg tubule pro-
LDL receptor knockout mouse experiments tein/mL and then divided into three equal aliquots and
incubated as follows: (1) control incubation30 minutesTo ascertain the impact of the LDL receptor (LDLR)
on renal cholesterol levels in the presence and absence (95% O2/5% CO2); (2) incubation with an Fe-mediated
oxidant challenge [25mol/L ferrous ammonium sulfate,of sepsis, eight female LDL knockout mice (B6.129S7-
Ldlrtm1Her) of three to five weeks of age were obtained complexed with hydroxyquinoline (FeHQ)] a sidero-
phore, allowing Fe to gain intracellular access [2]; andfrom Jackson Laboratory (Bar Harbor, ME, USA) [20].
Eight C57BL6J mice (Jackson Laboratory) of the same (3) 12.5 minutes of hypoxic incubation (95% N2/5% CO2)
followed by 17.5 minutes of re-oxygenation (95% O2/5%age were used as controls. The mice were maintained on
a regular rodent diet. The day of experimentation, four CO2) [16]. At the completion of the 30 minute incuba-
tions, cellular injury in the control and post-sepsis tubulesknockout mice and four control mice were injected with
2 mL of the E. coli suspension. Eighteen hours later, were contrasted by % LDH release [16]. Additionally,
the control incubated tubules from the normal and post-the mice were anesthetized with pentobarbital, and then
plasma was obtained from the inferior vena cava for sepsis mice were subjected to lipid extraction in chloro-
form:methanol and then analyzed for FC and CE content.BUN and cholesterol analysis. The kidneys were re-
moved and processed for renal cortical cholesterol (FC,
Calculations and statisticsCE) analysis by GC.
To assess baseline parameters, the remaining four All values are presented as means  1 SEM. Choles-
terol levels were expressed as nmol/mol phospholipidknockout mice and four control mice were anesthetized,
the abdominal cavities opened, and plasma and renal corti- phosphate (Pi). Results between groups were contrasted
by either the paired or unpaired Student t test. If multiplecal tissues were collected and analyzed, as noted above.
comparisons were made with any set of data, the Bonfer-
Impact of sepsis on isolated proximal tubule injury roni correction was applied. Statistical significance was
responses and cholesterol levels judged by a P value of 0.05.
The following experiment had two aims: (1) test whe-
ther cholesterol overload following sepsis is associated
RESULTS
with the cytoresistant state; and (2) ascertain whether
Effect of sepsis on renal cortical cholesterol levelsthe renal cortical cholesterol elevations were expressed
with/without statin therapyat the proximal tubular cell level. Five mice were injected
with 2 mL of heat-killed E. coli. Five simultaneously As shown in Figure 1, both free cholesterol (FC) and
cholesteryl esters (CEs) were significantly elevated bytreated mice received the E. coli vehicle. Eighteen hours
later, the mice were anesthetized with pentobarbital and 18 hours post-induction of sepsis, compared to controls.
The use of statin caused no significant decrease in thesethe kidneys were removed, and iced. The cortices were
dissected and then used to isolate proximal tubule seg- values. Figure 2 shows that the induction of sepsis also
induced a “pre-renal” like state, causing marked eleva-ments, as previously described in detail [16–18]. Tubules
from one control mouse and one post-sepsis mouse were tions in BUN (Fig. 2A), but not plasma creatinine con-
centrations (Fig. 2B). Supporting a hemodynamic, ratherstudied simultaneously. After completing a 15-minute
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Fig. 2. Effect of E. coli injection on blood urea nitrogen (BUN), creatinine, and plasma lactate dehydrogenase (LDH) levels in the presence or
absence of statins. E. coli-induced sepsis (S) caused a significant increase in BUN and LDH, but not in plasma creatinine levels. These changes
were not significantly blunted by concomitant statin treatment (S  statin).
Fig. 3. HMGCR mRNA, factored by GADPH
mRNA, following induction of sepsis syn-
drome. HMGCR mRNA levels were signifi-
cantly depressed in renal cortex 4 hours fol-
lowing E. coli injection, compared to paired
controls. However, by 18 hours post-sepsis,
HMGCR mRNA had returned to completely
normal values. This was despite marked tissue
cholesterol overload at this time, indicating a
lack of normal physiologic HMGCR mRNA
suppression.
than a structural, basis for this ARF are previous obser- the severity of sepsis, but given the highly variable nature
of the BUN/LDH increments, these changes did notvations of complete preservation of normal renal histol-
ogy in this sepsis model, despite the azotemic state [5]. achieve statistical significance.
The degree of azotemia was slightly lower in the statin
HMGCR mRNA analysis following sepsistreated animals, but this difference did not achieve statis-
tical significance. Sepsis also induced substantial, but highly Renal HMGCR mRNA levels were suppressed by
33% after four hours of sepsis (P  0.035), as depictedvariable, increases in the plasma LDH values (Fig. 2C).
As with the BUNs, the LDH values were modestly, but in Figure 3A. At this time, FC levels did not significantly
differ between the control and sepsis group (168  3not significantly, lower in the statin group. The LDH
values positively correlated with the prevailing BUNs and 178 3 nmol/mol phospholipid phosphate, respec-
tively). However, a slight increase in CE levels was ap-for both the control sepsis and statin treated groups (r
0.67, P  0.05; r  0.83, P  0.01; control and statin parent (Fig. 3B).
By 18 hours post-sepsis, HMGCR mRNA values weretreated groups, respectively; data not shown). Thus, in
summary, statin therapy appeared to slightly decrease identical for the control and sepsis groups (Fig. 3A). At
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Fig. 5. Scavenger receptor-B1 Western blots of control (C) renal corti-
cal tissues, and of renal tissues harvested either 4 or 18 hours post-
induction of sepsis (S). As is readily apparent, a profound suppression
of SR-B1 is apparent in the 18-hour post-sepsis samples. The 4 hour
samples did not significantly differ.
Fig. 4. HMGCR mRNA levels in kidney and liver following three days
of oral statin therapy. Statin treatment caused no significant change in
renal cortical HMGCR mRNA levels, compared to control kidney
values. However, statin treatment induced a dramatic increase in he-
patic HMGCR mRNA values. Hence, these results suggest that oral
statin treatment has hepatic, but not significant renal bioactivity.
this time point, the sepsis group manifested the charac-
teristic increases in FC (controls, 170  5; sepsis, 195  Fig. 6. Quantitation of SR-B1 in renal cortex by densitometric analysis
of Western blots. SR-B1 expression did not significantly differ from3; P  0.0001) and CE levels (Fig. 3B). At the 18-hour
normal at either 4 or 6 hours post-sepsis induction. However, by 18time point, the sepsis model once again induced a signifi-
hours, a marked reduction was apparent. Similarly, at 18 hours post-
cant increase in BUN concentrations (control BUNs, glycerol-induced rhabdomyolysis, SR-B1 levels were also significantly
suppressed.29  1; sepsis, 87  14 mg/dL; P  0.002). Sepsis also
caused a slight increase in serum cholesterol concentra-
tions (control, 127 4; sepsis, 149 8 mg/dL; P 0.04).
rect effect on renal HMGCR activity. [Indeed, the de-Impact of statin therapy on renal and hepatic
crease in renal CE levels could simply have reflected lowerHMGCR mRNA expression
CE uptake from the serum because of statin-induced re-
As shown in Figure 4, three days of statin therapy had ductions in cholesteryl ester levels.]
no discernible effect on renal cortical HMGCR mRNA
levels. In contrast, liver samples from these same animals SR-B1 expression
demonstrated that statin therapy caused an approximate Western blot analysis of post sepsis kidneys demon-
fourfold increase in HMGCR mRNA (a “positive con- strated a single band at approximately 55 kD (Fig. 5).
trol” for the negative kidney results). [Of note, HMGCR This band was completely absent when the anti-SR-B1
mRNA levels were markedly higher in liver vs. kidney primary antibody was deleted from the reaction. There
at baseline, consistent with the fact that the liver is the was no significant change in SR-B1 expression at either
dominant site of cholesterol synthesis.] four or six hours post-induction of the sepsis syndrome
(Fig. 6). However, by 18 hours post-sepsis, an approxi-
Statin effects on plasma and renal cortical cholesterol mate 70% reduction in SR-B1 was apparent (P 0.001).
levels in normal mice The corresponding cholesterol analysis performed on the
Serum cholesterols were reduced by approximately contralateral kidney from that used for Western blotting
25% after three days of statin therapy (134 12 vs.102 demonstrated that at four hours post-induction of sepsis,
11 mg/dL; P 0.01). Statin therapy also caused a modest no change in either FC (173  2 vs. 175  3) or in CE
decrease in renal cortical CE levels (3.8  0.3 vs. 3.1  levels (3.6  0.5 vs. 2.6  0.3) existed (control vs. sepsis,
0.4 nmol/mol Pi; P  0.015; controls vs. statin, respec- respectively). By six hours, a modest increase in FC
tively). In contrast, statin treatment had absolutely no (179  3 vs. 190  2; P  0.04), but not in CE (4.5 
effect on renal cortical FC levels (211  15 vs. 211  0.2 vs. 4.7  0.1; NS) was observed. However, by 18
17; control vs. statin, respectively). Thus, these data are hours post-sepsis, both FC (176  2 vs. 196  3; P 
consistent with the earlier HMGCR mRNA data: they 0.0001) and CE values (3.9  0.2 vs. 10.5  1.0; P 
0.0001) were elevated in the sepsis animals. The BUNseach imply that statin therapy had a minimal, if any, di-
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Fig. 7. Free cholesterol (FC) and cholesteryl ester (CE) levels in renal
cortex both under baseline conditions and 18 hours post-sepsis in
control (/) and LDL receptor knockout (/) mice. Baseline FC
levels were identical for both groups of mice, and each group mani-
fested essentially identical FC increases 18 hours post-induction of
sepsis. In contrast, the knockout mice had significantly higher CE levels Fig. 8. Total cholesterol levels in HK-2 cells following incubations
with either control or sepsis serum. Incubating cells with serum har-at baseline compared to the controls. However, each group developed
comparable (and significant) CE increases in response to sepsis. vested from septic mice caused a significant increase in cholesterol
levels (left panels). As shown in the middle panels, statin treatment (of
normal or septic serum) completely abolished this response. Incubating
cells with E. coli did not alter cholesterol levels (indicating that the
aforementioned cholesterol increase was not directly due to bacterialfor these animals were as follows: sepsis, 87  16; con- products).
trols, 31  1 mg/dL (P  0.01).
Western blotting of 18 hours post-glycerol-induced
rhabdomyolysis kidneys demonstrated an approximate
difference, and not a different degree of CE accumula-40% reduction in SR-B1 expression, compared to con-
tion in response to sepsis. Indeed, if the baseline differ-trols (Fig. 6). Hence, this reproduced the findings with
ence is subtracted from the post-sepsis difference, essen-the post-sepsis kidneys. The BUN values for the post-
tially identical CE elevations were apparent for the twoglycerol and control mice used for this experiment were
groups. Thus, loss of the LDL receptor did not alter the173  21 and 30  2 mg/dL, respectively (P  0.01).
sepsis-induced renal cholesterol accumulation. Interest-
LDL receptor knockout mouse experiments ingly, the decline in renal function post-sepsis was worse
in the knockout versus the control mice (BUN 92  6Baseline conditions. Baseline renal cortical FC and
mg/dL vs. 49  12 mg/dL respectively; P  0.035).CE levels in the LDLR knockout (/) mice and control
mice (/) are presented in Figure 7A. Renal cortical
HK-2 cell cholesterol levels following incubation withFC values were identical for the two groups. However,
“septic serum”as shown in Figure 7B, the knockout group did have a
Incubation of HK-2 cells with serum harvested fourhigher CE content (likely reflecting compensatory in-
hours after the induction of sepsis (septic serum, SS)creases in SR-B1 mediated CE uptake, as previously
demonstrated an approximate 40% increase in total cho-noted in this model [24]). As expected [20], serum choles-
lesterol levels, compared to cells subjected to controlterol values were significantly higher in the knockout
serum (CS) incubation (Fig. 8, left). When this experi-mice (212  6 mg/dL) compared to the controls (68 
ment was repeated in the presence of mevastatin4; P  0.001). This confirms successful induction of the
(“statin”), the septic serum was no longer able to increaseknockout state (which leads to hypercholesterolemia due
HK-2 cell cholesterol levels (Fig. 8, middle). At the timeto loss of the LDL receptor). Renal function for the
of serum harvesting, no difference in serum cholesterolcontrol and knockout mice appeared the same, at least
existed between these two groups (128  3 vs. 122 as assessed by BUN concentrations (28  2 and 29 
5 mg/dL; sepsis vs. controls). Unlike the results with2 mg/dL, respectively).
septic serum, addition of E. coli suspension did not alterPost-sepsis conditions. Both groups of mice responded
the cell cholesterol levels (Fig. 8, right).to sepsis with statistically significant increases in renal
cortical FC and CE concentrations (Fig. 7). In the case
Isolated proximal tubule segment (PTS) experimentsof FC, the post-sepsis increases were essentially identical
Isolated tubules harvested from the sepsis mice hadfor the two groups (Fig. 7A). The post-sepsis CE levels
statistically significant increases in both FC and CE con-were higher in the knockout mice versus the controls.
However, this difference simply reflected the baseline tent, compared to control tubules (FC, 225 3 vs. 181
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laboratory strongly suggest that both pre- and post-trans-
lational events can be involved [9].
Sepsis syndrome is one form of renal stress in which
cholesterol overload develops despite apparently normal
HMGCR protein expression [5]. This raises the question
as to whether constitutively expressed HMGCR could
be stimulated to drive cholesterol accumulation [26–30].
Any increase in tissue cholesterol levels resulting from
de novo synthesis would then be magnified if either exag-
gerated cell cholesterol uptake, or reduced cell efflux,
co-existed. The present study was designed to address
such possibilities.
Seemingly the best way to ascertain the contribution of
Fig. 9. Responses of isolated proximal tubules harvested from control HMGCR to sepsis-induced cholesterol accumulation
( ) and post-sepsis () mice to control oxygenated incubation, incuba- would be to treat animals with a statin and then deter-
tion with an oxidant challenge (FeHQ), or hypoxic/re-oxygenation
mine whether this abrogates the cholesterol overload(hypoxia) injury. Under each of these circumstances, the post-septic
tubules manifested less cell injury, as denoted by a significant decrease state. As depicted in Figure 1, oral statin therapy failed
in % LDH release. to significantly blunt post-sepsis cholesterol increments.
The bioactivity of the statin treatment protocol is indi-
cated by the fact that it successfully lowered serum cho-
lesterol levels. Therefore, if taken at face value, these3; P  0.002, respectively; CE, 6.7  0.8 vs. 1.0  0.1;
results suggest that HMGCR activity is not involved inP  0.002, respectively). This confirmed that the post-
sepsis-mediated renal cholesterol accumulation.sepsis FC/CE increases observed in whole renal cortex
A potential caveat to the above conclusion is thatreflected, at least in part, proximal tubular cell events.
statins undergo enterohepatic circulation, resulting inAs shown in Figure 9, PTS harvested from the post-sepsis
their being concentrated in liver. This raises the possibil-mice showed significantly less cell injury in response to
ity that minimal renal accumulation, and hence, bioactiv-
either the FeHQ-mediated oxidant challenge or hypoxia-
ity, results. If this is so, then the failure of statin treatment
reoxygenation injury. Even under control incubation to prevent sepsis-induced cholesterol accumulation could
conditions, the post-sepsis tubules manifested slightly not be taken as evidence against an HMGCR-dependent
greater cell viability than did the control tubules (Fig. 9). mechanism. To address this possibility, the relative im-
Thus, these proximal tubules exhibited cholesterol eleva- pact of statin therapy on renal HMGCR mRNA expres-
tions and partial resistance to injury, each characteristic sion was assessed. The rationale for this experiment is
of the stress-induced cytoresistant state [16–18]. that tissue HMGCR inhibition should cause a prompt
rise in message expression, thereby proving that renal-
specific bioactivity exists. As expected, statin therapy in-DISCUSSION
duced a fourfold rise in hepatic HMGCR mRNA, con-
Cholesterol accumulation following renal injury indi- firming activity in liver. However, no simultaneous change
cates marked dysregulation of a series of highly regu- in renal HMGCR mRNA resulted. Statin therapy also
lated, interactive processes that normally maintain tissue failed to induce any significant change in renal free cho-
cholesterol content within a narrow physiologic range. lesterol levels. Given these observations, it would appear
These processes include: (1) cholesterol uptake from that minimal, if any, statin bioactivity existed within the
plasma via LDL and non-LDL dependent pathways; (2) kidney. Hence, the negative results with statin therapy,
intrarenal cholesterol synthesis, with HMGCR being the as shown in Figure 1, cannot be taken as evidence against
critically regulated step; and (3) cellular cholesterol ef- HMGCR-mediated renal cholesterol accumulation. These
flux [19]. To date, our studies of post-renal injury choles- findings have implications far beyond the issue of mecha-
terol accumulation have elucidated only one abnormal- nisms of stress-induced renal cholesterol accumulation.
ity: an up-regulation of HMGCR protein that appears For example, it has been suggested that statins may slow
to drive excess cholesterol synthesis. This conclusion has the progression of chronic renal disease [31, 32]. How-
been based on the findings of increased HMGCR protein ever, if this is the case, the present results imply that such
in post-injured renal tissues by Western blotting [5], and an action might simply stem from changes in circulating
that statin treatment blocks cholesterol accumulation in lipids and/or cytokine expression, rather than a direct
post-injured cultured HK-2 cells [2]. The mechanism for intra-renal statin effect. However, at this time, we cannot
the increase in post-injury HMGCR protein remains in- exclude the possibility that statins might impact HMGCR
in specific cortical tissue compartments (for example,completely defined. However, recent studies from this
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endothelial or glomerular cells), since changes in their As previously noted, cellular cholesterol accumulation
could occur also via enhanced uptake from plasma cho-mRNA expression could have been masked by whole
cortex analysis. lesterol pools. For example, this might result from LDLR-
mediated cholesterol endocytosis [19, 20], or by choles-An intriguing question is whether ‘normal’ levels of
HMGCR protein in the setting of sepsis actually reflect teryl ester import via plasma membrane-associated SR-B1
[42–44]. The available evidence argues against these twodysregulation of the HMGCR axis. Under physiologic
conditions, cholesterol overload would be expected to possibilities. First, LDLR knockout mice did not have
blunted cholesterol accumulation in response to sepsis,down-regulate HMGCR expression due to suppression of
stimulatory transcription factor expression (most notably, seemingly excluding an LDLR-dependent mechanism.
Second, SR-B1 protein expression was clearly decreased,SREBP-2) [33–36]. This should then cause a sharp decline
in HMGCR mRNA, followed by reduced HMGCR pro- both in post-septic mice, as well as in another model of
renal cholesterol overload, that is, the glycerol model oftein. Thus, our previous observation that sepsis-induced
renal cholesterol accumulation is expressed in the pres- ARF. Thus, increased CE uptake via this pathway seems
unlikely. To our knowledge the present results are the firstence of “normal” HMGCR protein levels [5] suggests
that normal physiologic feedback inhibition did not to document reductions in SR-B1 following renal injury.
That it occurred in two highly divergent forms of renal in-exist. To explore this theme further, HMGCR mRNA
levels have now been assessed. At four hours post-sepsis, jury suggests that SR-B1 suppression could be a previously
unrecognized component of the renal stress response.HMGCR mRNA levels were suppressed, as would be
predicted by the above considerations. However, by 18 Scavenger receptor B1 is thought to serve a dual role
in cellular cholesterol homeostasis. As noted above, ithours post-sepsis, HMGCR mRNA levels no longer dif-
fered from those found in controls. This failure of sup- may be important in the selective uptake of circulating
cholestryl esters. However, it also plays a role in “reversepression, at a time of flagrant cholesterol overload, pro-
vides strong support for the concepts that dysregulation cholesterol transport,” a process that transfers intracellu-
lar free cholesterol to HDL particles at the plasma mem-of the renal HMGCR axis exists in sepsis, and that this
potentially contributes to the cholesterol overload state. brane with the latter leading to hepatic clearance [42–45].
Hence, the dramatic decrease in SR-B1 following renalTo gain further support for the concept of sepsis-
induced, HMGCR dependent, cholesterol synthesis, sep- injury has two implications for the present investigations:
first, it suggests that increased cholesteryl ester uptake issis was simulated in cultured HK-2 cells by the addition
of serum harvested from septic animals. Compared to an unlikely mechanism for cholesterol loading, as dis-
cussed above; and second, it provides support for theresults obtained with control serum, approximately a
40% increase in cellular cholesterol levels resulted. That concept that a decrease in cholesterol efflux may also
be operative. ABCA1 transporter is also a cholesterolmevastatin completely abrogated this response proves
that the HK-2 cell cholesterol increase was HMGCR- efflux pathway [21, 42–46]. However, it is minimally ex-
pressed in renal tissues, at least as assessed by a lack of itsdependent. It is notable that HK-2 cell cholesterol levels
remained normal following exposure just to E. coli in detection by Western blotting (unpublished data; RZ).
Given these observations, it seems unlikely that a fur-the presence of normal serum. Hence, sepsis-triggered
cytokines, or “stress factors,” rather than bacterial prod- ther-down regulation of the ABCA1 transport mecha-
nism exists. In summary, the available data suggest thatucts per se seemingly drove the enhanced HK-2 cell cho-
lesterol synthesis. The specific serum factor(s) responsi- sepsis-triggered renal cholesterol loading seemingly in-
volves: (a) HMGCR stimulation by circulating cyto-ble for this action remain to be defined. Nonetheless,
these in vitro data provide critical support for our con- kines/stress factors; and (b) marked reductions in SR-B1,
which presumably reduce cholesterol efflux, and hence,cept that sepsis-associated cholesterol accumulation oc-
curs, at least in part, by an HMGCR-dependent mecha- magnify the cholesterol overload state.
The final goal of this study was to confirm that sepsisnism. The results obtained with septic serum also provide
a completely new insight into mechanisms of stress-medi- syndrome, like other forms of renal injury, induces a cyto-
resistant state that is expressed directly at the cellularated renal cholesterol accumulation: they prove that the
latter is not strictly a renal injury-based phenomenon, level. For example, if proximal tubules are harvested from
mice or rats with post-glycerol ARF, post-ischemic ARFsince systemic factors can clearly impact the extent of
the renal cholesterol overload state. In this regard, it is or with urinary tract obstruction, they manifest increased
resistance to in vitro attack [16–18]. The present resultsnoteworthy that a number of cytokines and eicosinoids
can impact cellular cholesterol homeostasis, as well as indicate that sepsis-mediated renal stress is no exception,
given the finding of partial tubular cell resistance to hy-vice versa. This underscores the potential broad reaching
implications of the present observations vis-a-vis injury poxic and toxic attack. Thus, these findings provide in vitro
support for in vivo observations that post-endotoxin-responses at both the epithelial, and possibly the vascular
cell, level [37–41]. induced renal stress protects against ARF [47]. Choles-
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